2018Journal of Young PharmacistsOpen access

Nebivolol: An Appealing, Awaited and Nitric Oxide Potentiator Drug for the Treatment of Heart Failure

Aryendu Kumar Saini, Pranay Wal, Manisha Verma, Suresh Chandra, Anurag Singh, Sanjeev Kumar Yadav, Himanshu Bansode, Kumar Nischaya, Nikita Saraswat

Open full text 3 citations

Abstract

Published on:April 2018 Journal of Young Pharmacists, 2018; 10(2):149-154 Original Article | doi:10.5530/jyp.2018.10.34 Authors: Aryendu Kumar Saini1*, Pranay Wal1, Manisha Verma2, Suresh Chandra1, Anurag Singh1, Sanjeev Yadav1, Himanshu Bansode1, Kumar Nischaya1, Nikita Saraswat1 1Pharmacy Department, Pranveer Singh Institute of Technology, Kanpur, Uttar Pradesh, INDIA. 2Department of Clinical Research, National Institute of Pharmaceutical Education and Research,

Open-access reader

About this research paper

What this paper is about

Published on:April 2018 Journal of Young Pharmacists, 2018; 10(2):149-154 Original Article | doi:10.5530/jyp.2018.10.34 Authors: Aryendu Kumar Saini1*, Pranay Wal1, Manisha Verma2, Suresh Chandra1, Anurag Singh1, Sanjeev Yadav1, Himanshu Bansode1, Kumar Nischaya1, Nikita Saraswat1 1Pharmacy Department, Pranveer Singh Institute of Technology, Kanpur, Uttar Pradesh, INDIA. 2Department of Clinical Research, National Institute of Pharmaceutical Education and Research,

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Published on:April 2018 Journal of Young Pharmacists, 2018; 10(2):149-154 Original Article | doi:10.5530/jyp.2018.10.34 Authors: Aryendu Kumar Saini1*, Pranay Wal1, Manisha Verma2, Suresh Chandra1, Anurag Singh1, Sanjeev Yadav1, Himanshu Bansode1, Kumar Nischaya1, Nikita Saraswat1 1Pharmacy Department, Pranveer Singh Institute of Technology, Kanpur, Uttar Pradesh, INDIA. 2Department of Clinical Research, National Institute of Pharmaceutical Education and Research,

Key concepts: Nebivolol, Heart failure, Medicine, Cardiology, Beta blocker, Internal medicine, Nitric oxide, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Nebivolol: An Appealing, Awaited and Nitric Oxide Potentiator Drug for the Treatment of Heart Failure — Research Paper | ScholarLens